Publicaciones en colaboración con investigadores/as de Hospital Universitario San Cecilio (25)

2024

  1. Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial

    International Journal of Antimicrobial Agents, Vol. 63, Núm. 6

  2. Safety and Immunogenicity of the Nonavalent Human Papillomavirus Vaccine in Women Living with HIV

    Vaccines, Vol. 12, Núm. 8

  3. The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers

    Journal of Clinical Investigation, Vol. 134, Núm. 8

2023

  1. EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci

    International Journal of Antimicrobial Agents, Vol. 62, Núm. 3

2022

  1. Ampicillin plus ceftriaxone combined therapy for enterococcus faecalis infective endocarditis in opat

    Journal of Clinical Medicine, Vol. 11, Núm. 1

  2. DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks)

    Viruses, Vol. 14, Núm. 3

  3. Rildo: Real-World Multicenter Study on the Effectiveness and Safety of Single-Tablet Regimen of Dolutegravir plus Rilpivirine in Treatment-Experienced People Living with HIV

    Viruses, Vol. 14, Núm. 12

2021

  1. Blood culture-negative infective endocarditis: a worse outcome? Results from a large multicentre retrospective Spanish cohort study

    Infectious Diseases, Vol. 53, Núm. 10, pp. 755-763

2020

  1. Clinical and prognostic differences between methicillin-resistant and methicillin-susceptible Staphylococcus aureus infective endocarditis

    BMC Infectious Diseases, Vol. 20, Núm. 1

  2. Genetic diversity of HIV in seminal plasma remains higher than in blood after short-term antiretroviral therapy

    Sexually Transmitted Infections, Vol. 96, Núm. 5, pp. 337-341

2019

  1. DALBACEN cohort: Dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci

    Annals of Clinical Microbiology and Antimicrobials, Vol. 18, Núm. 1

  2. Left-sided infective endocarditis caused by Streptococcus agalactiae: rare and serious

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, Núm. 2, pp. 265-275

  3. Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort

    PLoS ONE, Vol. 14, Núm. 8

  4. Role of age and comorbidities in mortality of patients with infective endocarditis

    European Journal of Internal Medicine, Vol. 64, pp. 63-71

2018

  1. High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial

    PLoS ONE, Vol. 13, Núm. 4

  2. Prognostic implications of a negative echocardiography in patients with infective endocarditis

    European Journal of Internal Medicine, Vol. 52, pp. 40-48

2012

  1. Endocarditis de rápida evolución

    Medicina Clinica

  2. Registry of the Spanish Network for Systemic Sclerosis: Clinical Pattern According to Cutaneous Subsets and Immunological Status

    Seminars in Arthritis and Rheumatism, Vol. 41, Núm. 6, pp. 789-800

  3. Resistencia del virus de la hepatitis B al entecavir

    Medicina Clinica

2010

  1. Efficacy of cognitive behavioural therapy for the treatment of chronic stress in patients with lupus erythematosus: A randomized controlled trial

    Psychotherapy and Psychosomatics, Vol. 79, Núm. 2, pp. 107-115